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Objective:  To determine patients’ information, emotional and support needs at the 
completion of treatment for a haematological malignancy. Methods: A self-report 
questionnaire was mailed to 113 adult patients.  Results: Sixty-six questionnaires were 
returned. The most frequently endorsed patient needs related to care co-ordination and 
help to manage the fear of recurrence.  The most frequently endorsed unmet needs 
included managing the fear of recurrence, the need for a case-manager and the need for 
communication between treating doctors. Predictors of unmet needs included younger 
patients (p=0.01), marital status (p=0.03) and employment (p=0.03). Almost two thirds of 
patients (59%) reported they would have found it helpful to talk with a health care 
professional about their experience of diagnosis and treatment at the completion of 
treatment and endorsed significantly more need in the arenas of Quality of Life (p=0.03) 
and Emotional and Relationships (p=0.04). Conclusion: This study provides valuable 
data on haematological cancer patients’ needs in the first 12 months of finishing 
treatment.  It appears that many needs emerge or remain unresolved at this time.  
Practice implications: An opportunity for patients to talk with a health professional 
about making the transition from active treatment to extended survivorship may be 
helpful.   
 





Collectively, the haematological cancers are the fifth most common tumour group of 
adult Australians with an estimated 3,878 new cases of lymphoma and 1,049 cases of 
myeloma annually [1]. These are the two most common haematological cancers. 
Biologically, haematological cancers are cancers of the bone marrow (the leukemias) and 
the immune system (the lymphomas and myeloma) and effective treatment targeted at 
these organs necessarily has marked effects upon normal bone marrow and immune 
function. Consequently treatment is more complex and debilitating than other cancer 
treatments, with increased risk of severe infection, and more need for bone marrow 
support with red cell and platelet transfusions. The most complex treatments are 
autologous and particularly allogeneic bone marrow transplantation. The latter usually 
involves an in-patient stay of several weeks, with life-long subsequent follow up for most 
patients. Less intense out-patient-based therapies, such as CHOP chemotherapy for non-
Hodgkin lymphoma or induction regimens for myeloma, are also monitored every two to 
four weeks for periods of three to six months. Thus, during periods of treatment, 
haematological cancer patients may become heavily dependent upon hospital facilities 
and staff. Interaction with nursing staff on hospital wards may provide psychological 
support and many institutional haematology departments provide access to a social 
worker and liaison-psychiatrist. Some provide access to counselling and clinical 
psychologist support. The focus traditionally has been upon providing these supports 
during treatment.   
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The prevalence of psychological disorders in cancer populations during treatment is well 
documented [2].  In the largest study of adults diagnosed with cancer to date (n = 4,496), 
an overall rate of distress of 35% was found for the sample [3]. Anxiety was found to 
account for 30% of distressed cases, and depression for 19% of all cases reporting high 
levels of distress [3]. Other reactions reported in the literature include phobic reactions 
[4], and post-traumatic stress [5].  
 
An Australian study showed that 135/303 (45%) cancer patients had a psychiatric 
disorder of whom 127/303 (42%) were diagnosed with depression or anxiety, or both [4]. 
The prevalence of anxiety and depressive disorders in the general population of Australia 
is estimated to be approximately 9% [6]. While estimates vary depending on study 
populations and instruments used, the research literature provide strong evidence that a 
diagnosis of cancer places people at a far greater risk of psychological disorder compared 
to the general population.  
 
In haematological/lymphatic cancers, moderate to severe anxiety has been commonly 
reported [7]. Levels of psychological distress are likely to be higher when disease burden 
or complications are more severe.  For example, in patients who have had a bone marrow 
transplant, the level of anxiety was found to be significantly higher in those patients who 
went on to develop grade II-IV graft-versus-host disease (GVHD) compared to those who 
developed grade 0 – 1 GVHD. While the duration of PTSD following bone marrow 
transplant is unclear, one large study of patients with various cancer types found that, at 
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mean 4 year follow-up post transplant, patients with PTSD continued to show 
significantly poorer physical, social and role functioning [8].  
 
Research suggests that the needs of these distressed cancer patients are currently not 
adequately met by the health system. In an Australian study [9] 40% of cancer patients (n 
= 888) reported experiencing unmet needs across a range of domains. Factors associated 
with higher level of unmet needs in the psychological domain included not being in 
remission, younger (31-60 years), and female [9]. The development of measures in the 
late 1990’s to directly assess unmet needs improved upon previous methodology by 
directly measuring the gap between a person’s experience of a service and the actual 
service required [8,10]. This information permits the identification of high-risk groups 
likely to benefit from targeted preventative interventions.   
 
An examination of the literature on survivorship suggested that emotional distress and 
need for support do not cease for the survivor when treatment is completed and for many 
cancer patients, a greater psychological challenge lies in the resumption of life, work and 
relationships after treatment [11].  Two key documents published in 2006, the IOM report 
From Cancer Patient to Cancer Survivor: Lost in Transition (2007) [12] and a special 
issue of the Journal of Clinical Oncology addressing cancer survivorship (November 
2006), delineate a number of issues specific to the survivorship phase. These notably 
include fear of recurrence, persistent side effects such as fatigue, loss of fertility and 
altered body image, cognitive impairment [13, 14], loss of fertility and sexual function  
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[15, 16] and difficulty adjusting to normal life after the intense and life-changing 
experience of cancer [12, 17, 18]. Other themes described by cancer survivors include the 
struggle between independence and dependence, balance, a sense of wholeness, life 
purpose, reclaiming life, dealing with multiple losses, having control, the altered meaning 
of health, and surviving cancer from a family perspective [19].   
 
Another area of concern is re-engaging with or seeking employment once treatment is 
completed.  One large national survey showed that nearly one-fifth of the cancer 
survivors who worked before or after their cancer diagnosis experienced employment 
problems because of their cancer [20].  Unemployment and financial strain impose an 
additional psychological burden on cancer survivors [21]. 
 
It is clear that studies on survivorship issues are increasing.  This research highlights the 
need to be aware of the physical, emotional and social impact of cancer in the longer-
term but gives little insight into the shorter-term needs of patients on completing 
treatment.  As most studies reviewed did not include haematological malignancies in 
their sample, this study sought to address the gap in the literature by assessing the unmet 
informational and emotional needs of patients within the first year of completing 







2.1. Participants and recruitment 
 
Patients were eligible for inclusion in the study if they had completed chemotherapy or 
radiotherapy for haematological malignancies with the intention of cure or substantial 
remission; were aged 18-80; were not suffering from a mental illness, and could 
read/speak English proficiently.  Participants needed to be at a minimum 6 weeks from 
finishing treatment (to allow for re-staging and the follow-up consultation) and at a 
maximum 12 months from treatment (to capture bone marrow transplant patients who are 
on regular and longer follow-up). 
 
Participants were recruited through the Haematology Department at Sir Charles Gairdner 
Hospital and Royal Perth Hospital. All eligible participants were sent a letter inviting 
them to participate in the study by the Head of the Haematology Department and the 
treating clinician at each Institution.  This procedure ensured confidentiality of clinic 
records. An opt-out card was included for those who did not wish to participate or be 
contacted regarding this project. Patients for whom an opt-out card was not received were 
phoned by the researcher to explain the study, to answer questions, and to obtain verbal 
consent.  An information sheet, a consent form for written consent and the questionnaire 
battery was then mailed with a reply paid envelope. Non-returnees were mailed a 
reminder and replacement questionnaire after 2 weeks, and telephoned after a further two 
weeks. Ethical approval was obtained from the Sir Charles Gairdner Hospital Human 
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Research Ethics Committee, Royal Perth Hospital and the Edith Cowan University 
Human Research Ethics Committee. 
 
2.2 Measures  
 
Demographic characteristics: The survey collected data on demographic characteristics, 
for example age, education, occupation, employment status, marital status, diagnosis, 
date completed treatment, type of treatment. Patients were also asked their understanding 
of the current status of their cancer with options of a) cured, b) in remission, c) don’t 
know, and e) other. They were also asked if they considered themselves a cancer 
“survivor” with potential responses of “no”, “yes”, “not yet”, or “don’t know”.  Finally 
patients were asked if they would have found it helpful to speak to a health professional 
at the completion of their treatment about their experience of diagnosis, treatment and 
making the transition from active treatment. 
 
Information and emotional support needs:  The Cancer Survivors Unmet Needs 
measure (CaSUN) contains 35 supportive care need items, six positive outcome items 
and an open-ended item [21].   Psychometric evaluation supports the acceptability, 
internal consistency, construct and face validity and content validity of the measure.  
Factor analysis identified five distinct need domains with high internal consistency: (1) 
Existential Survivorship (e.g. “cope with changes to my beliefs”, “make decisions about 
my life in context of uncertainty”, “explore spiritual beliefs”); (2) Comprehensive Cancer 
Care (e.g. “doctors talk to each other”, “manage health care with team”, “local health 
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care services”); (3) Information (e.g. “up to date information”, “understandable 
information”); (4) QOL (e.g. “changes to quality of life”, “manage side effects”); and (5) 
Relationships (e.g. “impact on my relationship”, “problems with sex life”) [21].   
 
Respondents indicated whether they have no need (0), met need (1), weak unmet need 
(2), moderate unmet need (3), or strong unmet need (4) within the last month.  The 
number of met (scores of 1) and unmet needs (scores 2-4) are summed and total needs 
calculated from the sum of met and unmet needs. 
 
2.3 Data analysis 
 
Descriptive statistics, including means, medians, percentages, ranges and standard 
deviations were calculated as appropriate to describe the sample, and its characteristics.  
Comparisons between subgroups on demographic and disease variables (e.g. age, gender, 
educational level, occupational status, diagnosis, treatment modalities received, time 
since completion of treatment) were carried out using Chi Squared tests and Fisher’s 
Exact tests for categorical variables, t tests and analysis of variance for normally 
distributed continuous variables and Mann-Whitney and Kruskal-Wallis tests for ordinal 
or non-normally distributed continuous variables.  Correlations between measures were 
assessed using Pearson’s product-moment correlation coefficient and Spearman’s Rank 
Correlation coefficient, as appropriate. Due to the relatively small sample size, 
multivariate analyses were not carried out.   Qualitative data from responses to open 
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3.1 Demographic characteristics 
 
One hundred and thirty-three patients who had been diagnosed with a haematological 
malignancy and who had completed treatment between September 2005 and July 2006 
were recruited from two large hospitals in Perth.  Sixty-six self-report questionnaires 
were returned (50% response rate).  
 
The mean age was 54 (sd14.07, range 24 - 82 years). The majority were married (71%).  
Less than one-fifth (18%) were in full-time employment with around one-third retired 
(29%).   Just under half were either in professional employment or retired from 
professional employment (40%) and 44% were in non-professional employment.  One 
third of the sample (33%) was educated at year 10 or below.  (see Table 1) 
 
The mean number of months from completion of treatment was 8 months (sd 3.53, range 
2-13).  The main disease type represented in the sample was lymphoma (59%).  Fewer 
patients had Hodgkin lymphoma (12%), around one–third (32%) of participants indicated 
they had non-Hodgkin lymphoma, and 15% of participants indicated “lymphoma” 
without specifying the type.  Twenty-six percent (26%) of participants reported they had 
multiple myeloma.  Eleven percent (11%) of respondents had leukaemia. 
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The majority of the participants (59%) described their cancer status as “in remission” 
with 4% indicating “cured”.  Seventeen percent (17%) did not know their disease status. 
The majority of participants (54%) considered themselves a “survivor”; 36% indicated 
“not yet” and 3% didn’t know.  Four percent (4%) preferred different words to “survivor” 
(e.g., “living with it”, “winner”, fighter”, and “recovering”) and the remainder did not 
respond (3%). 
 
3.2 Views on health professional input at the time of treatment completion 
 
Almost two-thirds of respondents (59%) indicated that looking back over their experience 
of finishing treatment it would have been helpful at that time to talk with a health care 
professional about their experience of diagnosis and treatment and making the transition 
from active treatment. 
 
3.3 The needs of haematology cancer patients within the first year following 
treatment 
 
The mean number of needs identified by respondents on The Cancer Survivors Unmet 
Needs measure (CaSUN)  in Sub Scale A (Information Needs and Medical Care Issues) 
was 1.9, sd 2.57, range 0-9); in Sub-Scale B (Quality Life) mean 1.69, sd 2.12, range 0 – 
8); in Sub-Scale C (Emotional & Relationship Issues) mean 7.37, sd 4.95, range 3-12) 
and in Sub-Scale D (Life Perspective) mean 1.04, sd 2.51, range 0 – 6). 
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The ten most frequently endorsed patient needs are reported in Table 2.  These related to 
care co-ordination and help to manage the fear of recurrence.  The majority of 
participants reported the need to feel like they are managing their health together with the 
medical team (85%) to know that their doctors talk to each other to co-ordinate their care 
(82%) and to get the very best medical care (77%).  Seventy-three percent (73%) of 
participants reported the need for help to manage their concerns about the cancer coming 
back.  
 
3.4 Predictors of needs of haematology cancer patients within the first year following 
treatment 
 
Patients who reported that it would have been helpful to speak to a health professional at 
the completion of treatment endorsed significantly more need in the arenas of Quality of 
Life (z=-2.104, p = 0.03) and Emotional and Relationships (z = - 2.073, p = 0.04). 
Younger patients endorsed significantly more needs in the arena of Emotional and 
Relationship Issues (z= -2.69, p = 0.007).   
 
3.5 Unmet needs of haematology cancer patients within the first year following 
treatment 
 
The ten most frequently endorsed unmet patient needs are reported in Table 3.  These 
related to help in managing concerns about the cancer coming back (42%); an on-going 
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case manager to whom they can go to find out about services when they are needed 
(33%) and communication between doctors to co-ordinate care (31%).   The median 
number of unmet needs was 6 (sd 8.05, range 0 – 25).  
 
3.5 Predictors of unmet needs of haematology cancer patients within the first year 
following treatment 
 
Younger patients had a greater unmet need for help with concerns about recurrence than 
older patients (χ2=7.20 p = 0.007).  There was a trend for patients who were close to 
finishing treatment to have a greater unmet need for a case- manager (χ2=3.23, p = 0.06).  
Patients who were not married (χ2=4.51, p = 0.023) and patients who were working 
(χ2
 
=4.32, p=0.03) had a significantly greater unmet need for their doctors to talk to one 
another in co-ordinating their care.  




The area of psycho-oncology has traditionally focussed on the diagnosis and management 
of cancer, or its prevention.  With earlier detection of cancer and improved treatments, 
research is now shifting its focus to the increasing proportion of patients who survive 
cancer.  This is the first study to our knowledge that has assessed the unmet needs of 
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patients with haematological malignancies in the first twelve months after completing 
treatment, the period described as “extended survival” [22]. 
 
Approximately half of the patients who participated in this current study considered 
themselves “survivors”. The other half preferred to describe themselves as “in remission” 
from their disease. This is not surprising given that the average time since completion of 
treatment was only eight months.   
 
Previous studies reported that the needs most frequently endorsed by cancer survivors 
concerned “existential survivorship” (e.g. spiritual beliefs, the meaning of life) [23, 24] 
and comprehensive cancer care” (e.g. team care, communication, local health care 
services [24].  In the current study, 73% of participants expressed the need for help to 
manage their concerns about the cancer coming back with 43% considering this need 
unmet.  This is in contrast to previous Australian studies with gynaecological cancer 
patients [24] where the most frequently endorsed need concerned help managing the fear 
of recurrence (24%) and in breast cancer [23] where 33% of women endorsed managing 
the fear of disease recurrence as an unmet need. However, participants in these studies 
ranged from 1 to 10 years post diagnosis.   
 
A previous study of 888 cancer patients found factors associated with high levels of 
unmet needs in the psychological domain included not being in remission, being younger 
(31 to 60) years) and being female [9]. In this study also, younger patients expressed 
higher unmet needs for help with concerns about recurrence than older patients.  
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Similar to Hodgkinson and colleagues’ findings [23, 24], the most frequently reported 
needs for haematological patients at the time of completion of treatment related to care 
co-ordination. Patients who were not partnered and who were working had significantly 
greater unmet need for their doctors to talk to one another in co-ordinating their care.  
This finding suggests that time may be a factor and perhaps patients’ partners play a role 
in co-ordinating appointments and gathering information when the patient is working. 
Patients without a partner may be more reliant on health professionals to co-ordinate 
aspects of their care. 
 
Patients who were close to finishing treatment had a greater unmet need for a case 
manager which may be attributed to the higher percentage of patients in the study with 
lymphoma (59%) and who require monitoring every two to four weeks for periods of 
three to six months. A collaborative approach to care management was endorsed with 
patients wanting to be involved together with their medical team in managing their 
health. 
 
In the current study, younger patients endorsed significantly more needs around 
emotional and relationship issues following the completion of treatment.  This is in 
contrast to a study on supportive care needs where gynaecological cancer survivors 
reported normal relationship adjustment, although functioning was at the lower end [24].  
Whilst the number of respondents in the current study who underwent bone marrow 
transplantation is unknown, a previous study reported that sexual symptoms are 
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commonly reported by patients who have undergone bone marrow transplantation and 
may persist up to 12 months [25]. 
 
Fewer patients identified needs in the domains of information, medical care and quality 
of life. These findings corroborate qualitative findings gathered from telephone 
interviews with 20 patients in Stage 1 of the study [26] where the majority of patients 
reported being satisfied with the amount of information they received, their medical care 
and with their quality of life.  Although we are reporting data from a small sample of 
patients, it appears that having an opportunity to talk with a health professional on the 
completion of treatment would be helpful, with those patients endorsing significantly 




The routine assessment of unmet needs can generate local quality assurance information 
for service providers, and result in the development of recommendations regarding the 
optimal allocation and delivery of limited health care resources [27]. 
 
Further research is 
needed as the small sample size in this study is representative of two haematological 
cancer treatment centres in Perth, Western Australia and service provision may vary 
between clinics in other locations.  In addition, a larger sample size is required to 
accommodate different haematological cancers as treatments, such as bone marrow 
transplantation may produce different patient outcomes and hence different unmet needs.   
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4.3 Practice implications 
The IOM Report “From Cancer Patient to Cancer survivor: Lost in Transition” has 
specified four essential components of survivorship care that are important targets for 
survivorship planning: prevention of recurrent or new cancers, surveillance for new or 
recurrent cancers, medical and psychosocial late effects; intervention for the physical and 
psychosocial consequences of cancer and its treatment; and co-ordination between 
specialists and primary care providers [12].  In addition several authors have identified 
the need for further research into interventions that improve the quality of life and quality 
of care of cancer survivors [28,29] 
 
Our finding that patients who would have found it helpful to talk to a health professional 
at the completion of treatment had significantly more unmet needs in the areas of quality 
of life, emotions and relationships suggests that there is a sub group of patients who may 
benefit from an intervention in the form of a completion of treatment interview where the 
physical and psychosocial consequences of cancer and its treatment could be explored.  
 
If further research supports the findings that an opportunity to meet with a health 
professional at the completion of treatment is useful to patients, a protocol to inform the 
structure of such a completion interview could be developed.  This intervention, which 
would provide patients with the opportunity to talk with a health professional about their 
cancer journey through diagnosis, treatment and making the transition from active 
treatment to extended survivorship would need to be tested in a randomised controlled 
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trial to measure its impact on patients’ information, emotional and support needs, cancer 
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